Physician profile
Phillip T Zeni
NPI 1982719381
$44,172.15
in general payments reported to CMS, 2019-2025
28 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,905 · 2020: $5,060 · 2021: $5,455 · 2022: $5,026 · 2023: $5,248 · 2024: $7,674 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $20K · Food and Beverage: $4,344 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $19,733.34 |
| Food and Beverage | $4,343.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $649.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $36,241.10 | 2019-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $4,655.34 | 2021-2025 | In.Pact Admiral, Hawkone, Turbohawk |
| Endologix LLC | $670.88 | 2024-2025 | Endocross Device, Torus Stent Graft System |
| Inari Medical, INC. | $553.64 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Guerbet LLC | $322.49 | 2020-2022 | |
| Abbott Laboratories | $294.45 | 2021-2025 | Esprit, Diamondback Peripheral, Perclose Proglide |
| Medtronic Vascular, INC. | $263.27 | 2019 | |
| Terumo Medical Corporation | $210.63 | 2024-2025 | Angio-Seal, R2p Misago, Glidesheath Slender |
| Boston Scientific Corporation | $202.94 | 2020-2025 | Varithena Administration Pack, Enroute Transcarotid Stent |
| Asahi Intecc USA, INC. | $120.22 | 2025 | Asahi Coronary Wires |
| Smith+Nephew, INC. | $94.85 | 2024-2025 | Oasis Micro, Grafix Pl, Stravix Pl |
| Silk Road Medical, INC. | $81.77 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Varian Medical Systems, INC. | $72.01 | 2020 | |
| Becton, Dickinson and Company | $57.18 | 2024 | Fluency Endovascular Stent Graft |
| Reflow Medical INC | $46.33 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $36.82 | 2024-2025 | Brite Tip Radianz, Mynx Control |
| Convatec INC. | $32.83 | 2023 | |
| Siemens Medical Solutions USA, INC. | $27.55 | 2019 | |
| Myovant Sciences INC. | $25.76 | 2022 | |
| Argon Medical Devices, INC. | $22.90 | 2021 | |
| Penumbra, INC. | $20.19 | 2024 | Indigo System |
| W. L. Gore & Associates, INC. | $19.72 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Biocompatibles, INC. | $17.98 | 2019 | |
| Philips North America LLC | $17.45 | 2020 | |
| Surmodics, INC. | $17.15 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Merit Medical Systems INC | $17.00 | 2024 | |
| Solventum Corporation | $15.07 | 2024 | V.A.C. Veraflo, Activ.A.C. |
| Cardinal Health 200 LLC | $14.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Zeni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.